| 前收盘价格 | 34.37 |
| 收盘价格 | 33.83 |
| 成交量 | 519,311 |
| 平均成交量 (3个月) | 601,083 |
| 市值 | 1,555,837,696 |
| 价格/销量 (P/S) | 3.35 |
| 股市价格/股市净资产 (P/B) | 3.52 |
| 52周波幅 | |
| 利润日期 | 29 Apr 2025 - 5 May 2025 |
| 营业毛利率 | -9.61% |
| 营业利益率 (TTM) | -11.69% |
| 稀释每股收益 (EPS TTM) | -0.950 |
| 季度收入增长率 (YOY) | 16.60% |
| 总债务/股东权益 (D/E MRQ) | 16.60% |
| 流动比率 (MRQ) | 3.65 |
| 营业现金流 (OCF TTM) | 12.20 M |
| 杠杆自由现金流 (LFCF TTM) | -10.42 M |
| 资产报酬率 (ROA TTM) | -4.09% |
| 股东权益报酬率 (ROE TTM) | -9.64% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 混合的 | |
| 股票 | AtriCure, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
-0.5
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | -3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.50 |
|
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 3.49% |
| 机构持股比例 | 98.00% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 60.00 (JMP Securities, 88.50%) | 购买 |
| 中 | 50.00 (57.09%) | |
| 低 | 45.00 (Oppenheimer, 41.38%) | 购买 |
| 平均值 | 50.29 (58.00%) | |
| 总计 | 7 购买 | |
| 平均价格@调整类型 | 36.99 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 28 Mar 2025 | 52.00 (63.37%) | 购买 | 31.83 |
| 13 Feb 2025 | 66.00 (107.35%) | 购买 | 39.59 | |
| JP Morgan | 27 Mar 2025 | 46.00 (44.52%) | 购买 | 34.37 |
| 11 Feb 2025 | 51.00 (60.23%) | 购买 | 41.51 | |
| Needham | 27 Mar 2025 | 51.00 (60.23%) | 购买 | 34.37 |
| 21 Mar 2025 | 51.00 (60.23%) | 购买 | 33.54 | |
| JMP Securities | 13 Feb 2025 | 60.00 (88.50%) | 购买 | 39.59 |
| 10 Feb 2025 | 60.00 (88.50%) | 购买 | 42.02 | |
| Oppenheimer | 13 Feb 2025 | 45.00 (41.38%) | 购买 | 39.59 |
| Piper Sandler | 13 Feb 2025 | 50.00 (57.08%) | 购买 | 39.59 |
| Stifel | 13 Feb 2025 | 48.00 (50.80%) | 购买 | 39.59 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合